Hopwood Financial Services’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-950
Closed -$95.2K 300
2025
Q3
$95.2K Hold
950
0.06% 121
2025
Q2
$78.8K Hold
950
0.06% 123
2025
Q1
$77K Hold
950
0.06% 126
2024
Q4
$85.6K Buy
+950
New +$92K 0.06% 120

Other funds holding XBI

Hopwood Financial Services's XBI Position: Q4 2025 in Review

Hopwood Financial Services sold out of State Street SPDR S&P Biotech ETF (XBI) in Q4 2025, closing a stake of 950 shares — an estimated $95.2K sold.

Hopwood Financial Services first reported a position in XBI in Q4 2024 and held it in 4 quarters. The position peaked at $95.2K in Q3 2025. 814 funds tracked by Wall St. Rank hold XBI as of Q4 2025.

  • Hopwood Financial Services reported no remaining State Street SPDR S&P Biotech ETF position as of Q4 2025 after selling out during the quarter.
  • Hopwood Financial Services sold 950 State Street SPDR S&P Biotech ETF shares in Q4 2025, an estimated $95.2K.
  • Hopwood Financial Services first reported a position in State Street SPDR S&P Biotech ETF in Q4 2024 and held it in 4 quarters.
  • Hopwood Financial Services's State Street SPDR S&P Biotech ETF position peaked at $95.2K in Q3 2025.
  • 814 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q4 2025.

Based on Hopwood Financial Services's 13F filing for Q4 2025, filed 16 Jan 2026.